{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol%3A+Oral+administration", "query": { "intervention": "Alcohol: Oral administration" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 381, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol%3A+Oral+administration&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T19:06:25.309Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06293040", "title": "Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cannabis Intoxication", "Alcohol Intoxication" ], "interventions": [ { "name": "Cannabis", "type": "DRUG" }, { "name": "Alcohol", "type": "DRUG" }, { "name": "Placebo Cannabis", "type": "DRUG" }, { "name": "Placebo Alcohol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 90, "start_date": "2024-09-26", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06293040" }, { "nct_id": "NCT01411085", "title": "Risperidone and Desipramine in Alcohol Use and Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia", "Alcoholism", "Dual Diagnosis" ], "interventions": [ { "name": "Risperidone + Desipramine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2011-12", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2018-03-23", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 4, "location_summary": "Worcester, Massachusetts • Grand Rapids, Michigan • Lebanon, New Hampshire + 1 more", "locations": [ { "city": "Worcester", "state": "Massachusetts" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01411085" }, { "nct_id": "NCT02953548", "title": "Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infantile Spasms" ], "interventions": [ { "name": "GWP42003-P", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "24 Months", "sex": "ALL", "summary": "1 Month to 24 Months" }, "enrollment_count": 9, "start_date": "2017-04-24", "completion_date": "2018-05-07", "has_results": true, "last_update_posted_date": "2022-09-02", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 6, "location_summary": "Little Rock, Arkansas • Winston-Salem, North Carolina • Columbus, Ohio + 3 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02953548" }, { "nct_id": "NCT01537068", "title": "Desvenlafaxine vs. Placebo Treatment of Chronic Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dysthymic Disorder", "Dysthymia", "Chronic Depressive Disorder" ], "interventions": [ { "name": "Desvenlafaxine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "20 Years to 65 Years" }, "enrollment_count": 59, "start_date": "2012-02", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2017-09-11", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01537068" }, { "nct_id": "NCT00910689", "title": "Drug and Non-Drug Treatment Of Severe Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine Headache" ], "interventions": [ { "name": "Propranolol or nadolol", "type": "DRUG" }, { "name": "Placebo control", "type": "DRUG" }, { "name": "Behavioral Migraine Management (BMM)", "type": "BEHAVIORAL" }, { "name": "Optimal Acute Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Ohio University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 232, "start_date": "2001-07", "completion_date": "2005-11", "has_results": true, "last_update_posted_date": "2016-11-22", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 2, "location_summary": "Athens, Ohio • Westerville, Ohio", "locations": [ { "city": "Athens", "state": "Ohio" }, { "city": "Westerville", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00910689" }, { "nct_id": "NCT00402558", "title": "Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Myelodysplastic Syndrome", "Leukemia" ], "interventions": [ { "name": "Thymoglobulin", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Alloreactive NK Infusion", "type": "PROCEDURE" }, { "name": "G-CSF", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Interleukin-2", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "70 Years", "sex": "ALL", "summary": "Up to 70 Years" }, "enrollment_count": 15, "start_date": "2006-05", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2015-05-08", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00402558" }, { "nct_id": "NCT06160791", "title": "Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hemophagocytic Lymphohistiocytoses" ], "interventions": [ { "name": "Ruxolitinib", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Non-interventional Imaging", "type": "PROCEDURE" }, { "name": "Research Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Jerry Lee, MD, MSc, MPhil", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2024-10-01", "completion_date": "2029-11-30", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 4, "location_summary": "Irvine, California • Sacramento, California • San Diego, California + 1 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06160791" }, { "nct_id": "NCT05926024", "title": "Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Exercise Recall Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Health Behavior Questionnaire (HBQ)30 Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Functional Assessment of Cancer Therapy-General (FACT-G) Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PROMIS Cognitive Function (Short Form 8a)", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes Functional Assessment of Cancer-Gynecology Oncology Group-Neurotoxicity (FACT/GOG-NTX-12)", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PROMIS", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes FACT-Endocrine Symptoms", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes Penn Arthralgia Aging Survey", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PRO-CTCAE (patient-reported CTCAE)", "type": "BEHAVIORAL" }, { "name": "p16 tumor suppressor gene", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 253, "start_date": "2023-01-06", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05926024" }, { "nct_id": "NCT07153003", "title": "Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Post Operative Pain" ], "interventions": [ { "name": "Oxycodone", "type": "DRUG" }, { "name": "Tramadol and Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 560, "start_date": "2026-02-02", "completion_date": "2031-09-01", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07153003" }, { "nct_id": "NCT00607503", "title": "A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Terbutaline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jaeb Center for Health Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "12 Years to 18 Years" }, "enrollment_count": 9, "start_date": "2008-02", "completion_date": "2008-09", "has_results": false, "last_update_posted_date": "2016-09-05", "last_synced_at": "2026-09-27T19:06:25.309Z", "location_count": 6, "location_summary": "Stanford, California • New Haven, Connecticut • Jacksonville, Florida + 3 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00607503" } ] }